BioSpace News Archive

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the 41st Annual Cowen Healthcare Conference.

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter and full-year ended December 31, 2020.

Record net business wins in the quarter of $1,080 million; a book to bill of 1.42. Full year net business wins of $3.8 billion; a net book to bill of 1.38.

Harvard VIVID study tests whether vitamin D supplements reduce severity of symptoms and rate of hospitalizations or healthcare visits

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that three posters featuring data on smoker and e-cigarette user behavior will be presented , Wednesday, February 24th at the SRNT Annual Meeting being held virtually.

C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced that the Company will participate in the following upcoming March investor conferences: Cowen 41 st Annual Health Care Conference on Wednesday, March 3, 2021 at 11:40 a.m. ET

Deal led by Rock Springs Capital and joined by Bain Capital Life Sciences, Deerfield Management, RA Capital Management and other investors

The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced value to patients, customers, employees and shareholders.

Event to Showcase Epizyme’s Five-Year Corporate Strategy, TAZVERIK® Ongoing Development Plans and Advancements in the Company’s Epigenetic Pipeline

Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune function, thereby supporting general health and performance, is pleased to announce that it has chosen Meyenberg International Group to lead expansion efforts in key regions in Central and South America.